Real-World Upfront Combination Therapy with Macitentan and Tadalafil in Pulmonary Arterial Hypertension (PAH): Data from the Combined OPUS and OrPHeUS Datasets

被引:0
|
作者
Chin, K. M. [1 ]
Channick, R. [2 ]
McLaughlin, V. V. [3 ]
Melendres-Groves, L. [4 ]
Flynn, M. [5 ]
Leroy, S. [6 ]
Wetherill, G. [6 ]
Kim, N. H. [7 ]
机构
[1] UT Southwestern Med Ctr, Dallas, TX USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Univ New Mexico, Albuquerque, NM 87131 USA
[5] Actelion Pharmaceut US Inc, San Francisco, CA USA
[6] Actelion Pharmaceut Ltd, Allschwil, Switzerland
[7] Univ Calif San Diego, La Jolla, CA 92093 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2925
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Epidemiology and Treatment Patterns of Pulmonary Arterial Hypertension (PAH) Patients Across US Regions Using Real-World Data from OPUS/OrPHeUS
    Ravichandran, A.
    Zamanian, R.
    Channick, R.
    Chin, K.
    Kim, N.
    Martinez, E. C.
    Ong, R.
    Wetherill, G.
    McLaughlin, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [22] Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset
    Lammi, Matthew
    Chin, Kelly
    Kim, Nick H.
    McLaughlin, Vallerie
    Zamanian, Roham
    Flynn, Megan
    Leroy, Sandrine
    Ong, Rose
    Wetherill, Graham
    Channick, Richard
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [23] Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset
    Lammi, M. R.
    Chin, K.
    Kim, N. H.
    McLaughlin, V. V.
    Zamanian, R.
    Flynn, M.
    Leroy, S.
    Ong, R.
    Wetherill, G.
    Channick, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] CHARACTERISTICS, TREATMENT PATTERNS, AND OUTCOMES OF PULMONARY ARTERIAL HYPERTENSION PATIENTS BY ETHNICITY: REAL-WORLD DATA FROM THE COMBINED OPUS/ORPHEUS STUDIES
    Melendres-Groves, Lana
    Chin, Kelly
    Kim, Nick H.
    McLaughlin, Vallerie
    MacDonald, Gwen
    Martin, Nicolas
    Ong, Rose
    Sandros, Marinella
    Channick, Richard N.
    CHEST, 2024, 166 (04) : 5777A - 5780A
  • [25] CHARACTERISTICS, TREATMENT PATTERNS, AND OUTCOMES OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION BY RACE: REAL-WORLD DATA FROM THE COMBINED OPUS/ORPHEUS STUDIES
    McLaughlin, Vallerie
    Channick, Richard N.
    Melendres-Groves, Lana
    Chin, Kelly
    MacDonald, Gwen
    Martin, Nicolas
    Ong, Rose
    Sandros, Marinella
    Kim, Nick H.
    CHEST, 2024, 166 (04) : 5773A - 5776A
  • [26] SAFETY OF MACITENTAN IN PULMONARY HYPERTENSION PATIENTS WITH ELEVATED PULMONARY CAPILLARY WEDGE PRESSURE: REAL-WORLD EVIDENCE FROM OPUS/ORPHEUS
    Rahaghi, Franck
    Channick, Richard
    Kim, Nick
    Mclaughlin, Vallerie
    Martinez, Eliana
    Ong, Rose
    Wetherill, Graham
    Chin, Kelly
    CHEST, 2021, 160 (04) : 2275A - 2278A
  • [27] COMORBIDITIES IN PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM THE REAL-WORLD OPSUMIT® USERS (OPUS) REGISTRY
    Rajagopal, Sudarshan
    Channick, Richard
    Chin, Kelly
    Kim, Nick H.
    Flynn, Megan
    Leroy, Sandrine
    Ong, Rose
    Wetherill, Graham
    McLaughlin, Vallerie V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2101 - 2101
  • [28] Macitentan real-world experience in elderly patients over 75 years with pulmonary arterial hypertension (PAH)
    Kim, N.
    Channick, R.
    Chin, K.
    Mitchell, L.
    Turricchia, S.
    Ong, R.
    Mclaughlin, V
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [29] TREATMENT PATTERNS IN PULMONARY ARTERIAL HYPERTENSION: CHANGES IN CLINICAL PRACTICE OVER TIME USING REAL-WORLD EVIDENCE FROM THE COMBINED OPUS/ORPHEUS DATA SETS
    Chin, Kelly
    Channick, Richard
    McLaughlin, Vallerie
    Miller, Chad
    Flynn, Megan
    Ong, Rose
    Wetherill, Graham
    Kim, Nick
    CHEST, 2020, 158 (04) : 2194A - 2196A
  • [30] Macitentan tadalafil fixed dose combination (FDC) in patients with pulmonary arterial hypertension (PAH): A subgroup analysis from A DUE
    Jansa, Pavel
    Chin, Kelly
    Gruenig, Ekkehard
    Hauser, Jakob
    Pannaux, Matthieu
    Rofael, Hany
    Fan, Fenling
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62